Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Robert W. Baird

BioMarin Pharmaceutical Inc.
Start price
€76.16
13.07.23 / 50%
Target price
€113.58
13.07.24
Performance (%)
3.31%
End price
€78.68
14.07.24
Summary
This prediction ended on 14.07.24 with a price of €78.68. With a performance of 3.31%, the BUY prediction by Robert_W__Baird for BioMarin Pharmaceutical Inc. closed with a slight gain. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioMarin Pharmaceutical Inc. 0.192% 0.192% 3.860% -34.323%
iShares Core DAX® 0,85 % 0,39 % 2,53 % 52,00 %
iShares Nasdaq 100 -0,99 % -4,40 % 25,15 % 77,54 %
iShares Nikkei 225® -1,78 % -11,22 % 44,40 % 64,68 %
iShares S&P 500 0,06 % 0,78 % 20,95 % 63,01 %

Comments by Robert_W__Baird for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 3.31%
Target price 113.576
Change
Ends at 13.07.24

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $127.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Robert W. Baird 
0
Report Share
13.07.23
In the thread Trading BioMarin Pharmaceutical Inc.
Prediction Buy
Perf. (%) 3.31%
Target price 113.576
Change
Ends at 13.07.24

Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten

Robert W. Baird 
0
Report Share
14.07.24

Stopped prediction by Robert_W__Baird for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€82.64
30.01.24
€95.95
30.01.25
-25.00%
31.01.25

Robert W. Baird 
30.01.24 50%